OverviewSuggest Edit

22nd Century Group is a plant biotechnology company developing tobacco harm reduction and smoking cessation products. The Company's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.

TypePublic
Founded1998
HQClarence, US
Websitexxiicentury.com

Latest Updates

Employees (est.) (Feb 2019)82(+4%)
Revenue (FY, 2018)$26.4 M(+60%)
Share Price (Jun 2019)$2

Key People/Management at 22nd Century Group

Henry Sicignano

Henry Sicignano

President & Chief Executive Officer
Juan Sanchez Tamburrino

Juan Sanchez Tamburrino

Ph.D., Vice President of Research and Development
Paul Rushton

Paul Rushton

Ph.D., Vice President of Plant Biotechnology
John T. Brodfuehrer

John T. Brodfuehrer

CFO
Thomas L. James

Thomas L. James

., Vice President, General Counsel & Secretary
Michael Zercher

Michael Zercher

Vice President of Business Development
Show more

22nd Century Group Office Locations

22nd Century Group has an office in Clarence
Clarence, US (HQ)
9530 Main St
Show all (1)

22nd Century Group Financials and Metrics

22nd Century Group Revenue

22nd Century Group's revenue was reported to be $26.43 m in FY, 2018
USD

Revenue (Q2, 2019)

5.8m

Net income (Q2, 2019)

(8.0m)

EBIT (Q2, 2019)

(5.0m)

Market capitalization (10-Jun-2019)

254.3m

Closing stock price (10-Jun-2019)

2.0

Cash (30-Jun-2019)

874.4k

EV

254.6m
22nd Century Group's current market capitalization is $254.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

7.3m529.0k8.5m12.3m16.6m26.4m

Revenue growth, %

(93%)1511%44%

Cost of goods sold

498.4k9.1m12.7m

Gross profit

30.6k(580.6k)(429.7k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

52.5k2.8m3.1m2.2m3.9m4.5m6.1m6.9m6.3m6.3m5.8m

Cost of goods sold

20.6k2.9m

Gross profit

32.0k

Gross profit Margin, %

61%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

5.8m6.4m3.8m13.5m3.7m604.9k

Accounts Receivable

51.2k41.0k957.1k871.3k

Inventories

1.4m2.7m3.1m3.3m3.0m

Current Assets

7.7m10.7m7.2m16.8m67.6m61.2m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

1.0m5.4m4.2m10.0m3.8m8.2m6.7m6.1m2.8m5.2m10.7m12.5m15.0m5.5m3.4m759.2k589.0k874.4k

Accounts Receivable

16.1k209.0k449.5k225.4k102.9k105.7k16.5k2.1k717.9k126.2k676.2k1.3m936.2k1.5m910.7k

Inventories

1.3m1.7m1.7m1.7m2.6m2.4m2.4m2.9m3.1m3.0m3.0m4.3m4.0m3.2m2.9m3.3m3.3m2.9m

Current Assets

2.4m7.3m6.2m16.0m7.1m12.1m9.9m9.6m6.8m8.7m14.2m18.0m19.7m64.3m59.0m67.7m57.5m52.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(26.2m)(15.6m)(11.0m)(11.6m)(13.0m)(8.0m)

Depreciation and Amortization

144.3k462.8k319.7k744.2k849.0k1.2m

Inventories

(175.8k)(620.7k)(701.5k)(531.4k)(129.2k)333.6k

Accounts Payable

(629.1k)625.4k86.3k(136.3k)473.8k323.1k
USDY, 2019

EV/EBIT

-57 x

EV/CFO

-32.8 x

Financial Leverage

1.1 x
Show all financial metrics

22nd Century Group Online and Social Media Presence

Embed Graph

22nd Century Group News and Updates

Thinking about buying stock in Atossa Genetics, Cronos Group, New Age Beverages Co, Tesaro Inc. or 22nd Century Group Inc.?

NEW YORK, Dec. 4, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATOS, CRON, NBEV, TSRO, and XXII. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ...

Scott+Scott Attorneys at Law LLP Announces Investigation into 22nd Century Group, Inc. (XXII)

NEW YORK, Nov. 13, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether 22nd Century Group, Inc. ("22nd Century" or the "Company") (NYSE American: XXII) or certain of its officers and...

22nd Century Group Blogs

22nd Century Group Appoints Michael J. Zercher as Chief Operating Officer

WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis research, announced today the appointment of Micha…

22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update

22nd Century’s proposed VLN™ cigarettes continue to fall squarely within the nicotine range that public health officials anticipate will be mandated by the FDA. Company’s financial position remains strong; cash, cash equivalents, and short-term investment se…

22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection

FDA Inspection is an important milestone for 22nd Century’s VLN™ Cigarettes WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low N…

Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders

22nd Century exposes short seller as a promotor of incorrect and self-serving “fake news” WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduct…

22nd Century Group Hires Former Imperial Brands Head of Regulatory Science

WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today the hiring of John D. Pritchard …

22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis

Strategic collaboration will bolster 22nd Century’s position as a global leader in hemp/cannabis genetics. WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)-- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm …
Show more

22nd Century Group Frequently Asked Questions

  • When was 22nd Century Group founded?

    22nd Century Group was founded in 1998.

  • Who are 22nd Century Group key executives?

    22nd Century Group's key executives are Henry Sicignano, Juan Sanchez Tamburrino and Paul Rushton.

  • How many employees does 22nd Century Group have?

    22nd Century Group has 82 employees.

  • What is 22nd Century Group revenue?

    Latest 22nd Century Group annual revenue is $26.4 m.

  • What is 22nd Century Group revenue per employee?

    Latest 22nd Century Group revenue per employee is $322.3 k.

  • Who are 22nd Century Group competitors?

    Competitors of 22nd Century Group include Sundial Growers, NewBridge Global Ventures and TTS Pharma.

  • Where is 22nd Century Group headquarters?

    22nd Century Group headquarters is located at 9530 Main St, Clarence.

  • Where are 22nd Century Group offices?

    22nd Century Group has an office in Clarence.

  • How many offices does 22nd Century Group have?

    22nd Century Group has 1 office.